Chemed Corporation Stock News

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Direct...

MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer...

Chemed Corporation (NYSE:CHE ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Holley Schmidt - Corporate Participant Kevin J. McNamara - CEO, President & Director Michael D.

Chemed (CHE -9.17%) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year...

Chemed Corporation's diversified revenue streams from VITAS Healthcare and Roto-Rooter provide a strong competitive advantage and resilience against sector-specific risks. Recent VITAS acquisition and expansion, along with robust Q1 results, highlight the company's growth potential and operational strength, especially in hospice care. My DCF analysis suggests Chemed is undervalued by over 50%, ...

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed ...

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Divid...